Applying a phase II futility study design to therapeutic stroke trials
Stroke. 2005 October 13; 36 (11) 2410-4.
PubMed:
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort
Neurology. 2004 August 10; 10 (63) 468-74.
PubMed:
Can we predict early recurrence in acute stroke?
Cerebrovasc Dis. 2004 June 23; 18 (2) 139-44.
PubMed:
Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST)
Stroke. 2001 December 1; 32 (12) 2836-40.
PubMed:
Circadian variation in ischemic stroke subtypes
Stroke. 1999 September; 30 (9) 1792-5.
PubMed:
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Neurology. 1999 July 13; 13 (53) 126-31.
PubMed:
Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators
Neurology. 1999 January 15; 15 (52) 280-4.
PubMed:
Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Controlled Clinical Trials. 1997 August; 18 (4) 358-377.
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators.
Neurology. 1993 May; 43 (5) 1021-7.
PubMed: